Global Point-of-Care Infectious Disease Diagnostics Market Overview:
Global Point-of-Care Infectious Disease Diagnostics Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Point-of-Care Infectious Disease Diagnostics Market Report 2025 comes with the extensive industry analysis with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Point-of-Care Infectious Disease Diagnostics involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Point-of-Care Infectious Disease Diagnostics Market:
The Point-of-Care Infectious Disease Diagnostics Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Point-of-Care Infectious Disease Diagnostics Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Point-of-Care Infectious Disease Diagnostics Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Point-of-Care Infectious Disease Diagnostics market has been segmented into:
Lateral Flow Immunoassay
Flow-through Test
Molecular Diagnostics
Agglutination Test
Other Techniques
By Application, Point-of-Care Infectious Disease Diagnostics market has been segmented into:
Clinics End-Use
Hospitals End-Use
Home End-Use
Assisted Living Healthcare Facilities End-Use
Other End-Uses).
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Point-of-Care Infectious Disease Diagnostics market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Point-of-Care Infectious Disease Diagnostics market.
Top Key Players Covered in Point-of-Care Infectious Disease Diagnostics market are:
AccuBioTech Co. Ltd.
Agilent Technologies Inc.
BioFire Diagnostics LLC
bioMerieux SA
Bio-Rad Laboratories Inc.
Cardinal Health Inc.
Cepheid
Chembio Diagnostic Systems Inc.
Danaher Corporation
EKF Diagnostics Holdings PLC
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Point-of-Care Infectious Disease Diagnostics Market Type
4.1 Point-of-Care Infectious Disease Diagnostics Market Snapshot and Growth Engine
4.2 Point-of-Care Infectious Disease Diagnostics Market Overview
4.3 Lateral Flow Immunoassay
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Lateral Flow Immunoassay: Geographic Segmentation Analysis
4.4 Flow-through Test
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Flow-through Test: Geographic Segmentation Analysis
4.5 Molecular Diagnostics
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Molecular Diagnostics: Geographic Segmentation Analysis
4.6 Agglutination Test
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Agglutination Test: Geographic Segmentation Analysis
4.7 Other Techniques
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Other Techniques: Geographic Segmentation Analysis
Chapter 5: Point-of-Care Infectious Disease Diagnostics Market Application
5.1 Point-of-Care Infectious Disease Diagnostics Market Snapshot and Growth Engine
5.2 Point-of-Care Infectious Disease Diagnostics Market Overview
5.3 Clinics End-Use
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Clinics End-Use: Geographic Segmentation Analysis
5.4 Hospitals End-Use
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Hospitals End-Use: Geographic Segmentation Analysis
5.5 Home End-Use
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Home End-Use: Geographic Segmentation Analysis
5.6 Assisted Living Healthcare Facilities End-Use
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Assisted Living Healthcare Facilities End-Use: Geographic Segmentation Analysis
5.7 Other End-Uses).
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Other End-Uses).: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Point-of-Care Infectious Disease Diagnostics Market Share by Manufacturer (2025)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ACCUBIOTECH CO.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 LTD.; AGILENT TECHNOLOGIES
6.4 INC.; BIOFIRE DIAGNOSTICS LLC; BIOMERIEUX SA; BIO-RAD LABORATORIES
6.5 INC.; CARDINAL HEALTH
6.6 INC.; CEPHEID; CHEMBIO DIAGNOSTIC SYSTEMS
6.7 INC.; DANAHER CORPORATION; EKF DIAGNOSTICS HOLDINGS PLC
Chapter 7: Global Point-of-Care Infectious Disease Diagnostics Market By Region
7.1 Overview
7.2. North America Point-of-Care Infectious Disease Diagnostics Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Lateral Flow Immunoassay
7.2.2.2 Flow-through Test
7.2.2.3 Molecular Diagnostics
7.2.2.4 Agglutination Test
7.2.2.5 Other Techniques
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Clinics End-Use
7.2.3.2 Hospitals End-Use
7.2.3.3 Home End-Use
7.2.3.4 Assisted Living Healthcare Facilities End-Use
7.2.3.5 Other End-Uses).
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Point-of-Care Infectious Disease Diagnostics Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Lateral Flow Immunoassay
7.3.2.2 Flow-through Test
7.3.2.3 Molecular Diagnostics
7.3.2.4 Agglutination Test
7.3.2.5 Other Techniques
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Clinics End-Use
7.3.3.2 Hospitals End-Use
7.3.3.3 Home End-Use
7.3.3.4 Assisted Living Healthcare Facilities End-Use
7.3.3.5 Other End-Uses).
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Point-of-Care Infectious Disease Diagnostics Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Lateral Flow Immunoassay
7.4.2.2 Flow-through Test
7.4.2.3 Molecular Diagnostics
7.4.2.4 Agglutination Test
7.4.2.5 Other Techniques
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Clinics End-Use
7.4.3.2 Hospitals End-Use
7.4.3.3 Home End-Use
7.4.3.4 Assisted Living Healthcare Facilities End-Use
7.4.3.5 Other End-Uses).
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Point-of-Care Infectious Disease Diagnostics Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Lateral Flow Immunoassay
7.5.2.2 Flow-through Test
7.5.2.3 Molecular Diagnostics
7.5.2.4 Agglutination Test
7.5.2.5 Other Techniques
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Clinics End-Use
7.5.3.2 Hospitals End-Use
7.5.3.3 Home End-Use
7.5.3.4 Assisted Living Healthcare Facilities End-Use
7.5.3.5 Other End-Uses).
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Point-of-Care Infectious Disease Diagnostics Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Lateral Flow Immunoassay
7.6.2.2 Flow-through Test
7.6.2.3 Molecular Diagnostics
7.6.2.4 Agglutination Test
7.6.2.5 Other Techniques
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Clinics End-Use
7.6.3.2 Hospitals End-Use
7.6.3.3 Home End-Use
7.6.3.4 Assisted Living Healthcare Facilities End-Use
7.6.3.5 Other End-Uses).
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Point-of-Care Infectious Disease Diagnostics Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Lateral Flow Immunoassay
7.7.2.2 Flow-through Test
7.7.2.3 Molecular Diagnostics
7.7.2.4 Agglutination Test
7.7.2.5 Other Techniques
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Clinics End-Use
7.7.3.2 Hospitals End-Use
7.7.3.3 Home End-Use
7.7.3.4 Assisted Living Healthcare Facilities End-Use
7.7.3.5 Other End-Uses).
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Point-of-Care Infectious Disease Diagnostics Scope:
|
Report Data
|
Point-of-Care Infectious Disease Diagnostics Market
|
|
Point-of-Care Infectious Disease Diagnostics Market Size in 2025
|
USD XX million
|
|
Point-of-Care Infectious Disease Diagnostics CAGR 2025 - 2032
|
XX%
|
|
Point-of-Care Infectious Disease Diagnostics Base Year
|
2024
|
|
Point-of-Care Infectious Disease Diagnostics Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
AccuBioTech Co. Ltd., Agilent Technologies Inc., BioFire Diagnostics LLC, bioMerieux SA, Bio-Rad Laboratories Inc., Cardinal Health Inc., Cepheid, Chembio Diagnostic Systems Inc., Danaher Corporation, EKF Diagnostics Holdings PLC.
|
|
Key Segments
|
By Type
Lateral Flow Immunoassay
Flow-through Test
Molecular Diagnostics
Agglutination Test
Other Techniques
By Applications
Clinics End-Use
Hospitals End-Use
Home End-Use
Assisted Living Healthcare Facilities End-Use
Other End-Uses).
|
